The District of Delaware’s revised Local Rules for civil cases will take effect August 1, 2016. A copy of the revised Local Rules is linked below.
We previously reported on Judge Sleet’s in limine rulings directed to Section 271(f) and European Patent Office proceedings in patent litigation related to aortic valve stents between Edwards Lifesciences and Medtronic Corevalve. After a jury trial last week, the jury awarded Edwards Lifesciences lost profit damages and reasonable royalties.
The verdict form has been made public and shows that the jury found direct infringement, willful infringement, infringement pursuant to Section 271(f), and that the patents-in-suit were valid. The jury awarded $388.8 million of lost profits and $4.8 million of reasonable royalty for infringing sales not subject to lost profits.
Delaware IP Law Blog Author, Greg Brodzik, and Contributor, Jim Lennon, were invited by IPWatchdog.com to comment on the Supreme Court’s recent decision in Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al., 569 U.S. ___, on the scope of patent eligibility in the context of DNA discoveries. Follow this link to their post on IPWatchdog.com: Myriad: Positive Implications for Genetic Research, but Some Questions Remain Unanswered